Andreas Koller

Andreas Koller is a Researcher at the Department of Ophthalmology within the Research Program of Experimental Ophthalmology and Glaucoma Research at the Salk Institute. His work focuses on the intersection of neurodegenerative diseases, ophthalmology, and immunology, particularly investigating mechanisms related to retinal health and aging.

Andreas has led and co-led multiple research projects, including studies on mitochondrial energy metabolism analysis (2017–2018) and the role of the regulatory peptide galanin in immune cell differentiation and function. His research output spans 2015–2025, with a particular emphasis on Alzheimer's disease, gut microbiota, and leukotriene receptor biology.

Key research trends include neuroimmunology, retinal degeneration, and metabolic interventions in aging models. His work has been cited in Web of Science and disseminated through peer-reviewed journals and scientific outreach on platforms like Mendeley and Bluesky.

He actively collaborates on experimental ophthalmology and glaucoma research, contributing to understanding how inflammatory pathways and metabolic factors influence retinal and neuronal health.